According to the publisher, Colombia gene editing technology market size is expected to record a CAGR of 7.7% during 2023-2027 to reach US$0.061 billion by 2027, increasing from US$0.042 billion in 2023. Over the last five years, the sector has recorded a CAGR of 9.0% to reach US$0.039.2 billion in 2022.
This report provides an in-depth data-centric analysis of the emerging opportunities in gene editing industry. It covers a detailed view of market size and forecast across various segments such as gene editing technologies (CRISPR, meganucleases, TALEN, and ZFN), by products, delivery method, disease/disorders, and application.
This databook is a part of the title “Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update”.
This report provides an in-depth data-centric analysis of the emerging opportunities in gene editing industry. It covers a detailed view of market size and forecast across various segments such as gene editing technologies (CRISPR, meganucleases, TALEN, and ZFN), by products, delivery method, disease/disorders, and application.
This databook is a part of the title “Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update”.
Scope
This report provides an in-depth, data-centric analysis of the Colombia gene editing market 2018-2027. Below is a summary of key market segments:By Technology
- CRISPR CAS 9
- TALENs
- ZFN
- Others (Meganucleases)
By CRISPR PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By TALENs PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By ZFNs PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By Meganucleases PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By Delivery Method
- Ex-vivo
- In-vivo
By Disease/Disorders
- Cancer
- Blood Disorders (beta-thalassemia and sickle cell disease)
- Blindness
- Respiratory Disease (COVID-19 & Cystic fibrosis)
- Others (AIDS, Huntington’s disease, Muscular dystrophy)
By Application
- Drug Development
- Diagnostics
- Plant Gene Editing
- Others (Animal Gene Editing)
By End-User
- Pharmaceutical and Biopharmaceutical Companies
- Biotechnology Companies
- Contract Research Organisations
- Academic Institutes and Research Centres
Reasons to buy
- In-depth understanding of gene editing market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in Colombia.
- Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
- Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and contract research organisations.
Table of Contents
1 Colombia Gene Editing Technology Market Size and Forecast, 2018-2027
2 Gene Editing Technology Market Size by Technology, 2018-2027
3 Gene Editing Technology Market Size by CRISPR Product, 2018-2027
4 Gene Editing Technology Market Size by TALENs Product, 2018-2027
5 Gene Editing Technology Market Size by ZFNs Product, 2018-2027
6 Gene Editing Technology Market Size by Meganucleases Product, 2018-2027
7 Gene Editing Technology Market Size by Delivery Mode, 2018-2027
8 Gene Editing Technology Market Size by Diseases/Disorders, 2018-2027
9 Gene Editing Technology Market Size by Application, 2018-2027
10 Gene Editing Technology Market Size by End Users, 2018-2027
